Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
February 2003
Features
Cover Story
Meta-analysis: Effect of ACE-Inhibitors on Outcomes in Patients with Renal Insufficiency
The authors explain the benefits of ACE-inhibitors in controlling the progression of renal disease.
Tomoko Terajima, MS Pharm, Shin-ichi Yamagata, MS Pharm, Nobunori Satoh, PhD, and Shiro Ueda, MD
Physician Perspective
The Struggle to Heal an Angry Patient
A family practitioner discovers some of the lessons to be learned from treating a terminally ill patient.
Thomas Marzili, MD
Pharmaceutical-Approval Update
Pharmaceutical-Approval Update
The author reviews ezetimibe for lowering blood lipid levels, atomoxetine for attention-deficit hyperactivity disorder, and injectable teriparatide for osteoporosis.
Marvin M. Goldenberg, PhD
Letter to the Editor
Direct-to-Consumer Marketing Generates Calls: Is the Pharmaceutical Industry Prepared?
Drug companies can satisfy their customers by responding to their increasing demands for information.
Paul Spiegelman
CE/CME
Imiquimod Cream: A New Multipurpose Topical Therapy for Dermatology
The authors discuss a new topical therapeutic agent for the treatment of genital warts and other skin conditions.
David J. Najarian, BS, and Joseph C. English III, MD
Departments
Editorial
California’s Integrated Healthcare Association
Editor-in-Chief Dr. David Nash reports on California’s Integrated Healthcare Association.
David B. Nash, MD, MBA
Medication Errors
Computer-Generated MAR Format: A Source of Errors?
Matthew Grissinger describes the potential pitfalls of pharmacy computer-generated medication administration records.
Matthew Grissinger
Drug News
New Drugs/Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Prescription Washington
FDA’s Proposal on Generics Pleases No One
Stephen Barlas discusses the FDA’s latest proposal on generic drugs.
Stephen Barlas
Drug Forecast
Eplerenone: A Novel Selective Aldosterone Blocker for Hypertension
Drs. Kleyman and Sisca review eplerenone for the treatment of hypertension.
Jennie Kleyman, PharmD, and Thomas S. Sisca, PharmD
P&T Snapshot
Treating Hypertension: Beta Blockers Surpass ACE-Inhibitors
Both ACE-inhibitors and beta blockers are commonly prescribed for patients with hypertension, but the numbers are changing.
